Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

MOA is Mechanism of Action, not method of action.

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153798
(Total Views: 709)
Posted On: 10/13/2020 2:50:13 AM
Posted By: Dr.Acula
Re: jamming1092 #60861
MOA is Mechanism of Action, not method of action.

You wrote: "TLDR : It is not an anti viral. It changes the polarity of the response so that it is anti inflammatory. This turbo charges the normal immune system (instead of over loading it , exhausting it). The immune system then just does its thing at full power. It is this immune system response that reduces the viral load."

Read More: https://investorshangout.com/post/newpost/605...z6ajP7j5lJ


I think you're trying reference Bruce's TedX talk, which is a succinct lecture and worth watching, however I take issue with this vague and inaccurate explanation of why Leronlimab isn't an antiviral, followed by some "turbo charged" business which isn't true. Nothing is "turbo charged." or "at full power". PRO140 isn't a car.

To be precise, Leronlimab or PRO 140 is a lab-made antibody that functions as an entry inhibitor.

Entry inhibitors, also known as fusion inhibitors, are a class of antiviral drugs that prevent a virus from entering a cell, for example, by blocking a receptor.

Entry inhibitors are used to treat conditions such as HIV and hepatitis D.

PRO 140, the anti-CCR5 monoclonal antibody, can stop HIV from entering the cell and stop viral replication. It prevents the virus-cell binding at a distinct site in the CCR5 co-receptor without interfering with its natural activity. Unlike other entry inhibitors, PRO 140 is a monoclonal antibody. The mechanism of inhibition is competitive rather than allosteric.

This is in regards to HIV.

In regards to COVID-19, there is a hyper-immune response due to what Dr. Patterson has called "emerging virus" (We have no antibodies, never saw this virus before, in TedTalk) What he observed in his paper, which I established a link to in days past, is worth a read for you to learn, please read it to understand the MOA.

Repolarization of macrophages was described in an animated MOA for breast cancer.

Try not to conflate the MOA in HIV with COVID-19 with Triple Negative Metastatic Breast Cancer, it is confusing.

This is meant to clarify for readers. Nothing personal Jamming.




(6)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us